News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,754 Results
Type
Article (39520)
Company Profile (311)
Press Release (650923)
Section
Business (204819)
Career Advice (2009)
Deals (35483)
Drug Delivery (91)
Drug Development (81040)
Employer Resources (168)
FDA (16128)
Job Trends (14863)
News (345904)
Policy (32561)
Tag
Academia (2548)
Alliances (49527)
Alzheimer's disease (1263)
Approvals (16078)
Artificial intelligence (144)
Bankruptcy (354)
Best Places to Work (11603)
Biotechnology (218)
Breast cancer (189)
Cancer (1367)
Cardiovascular disease (110)
Career advice (1676)
Cell therapy (283)
Clinical research (64815)
Collaboration (484)
Compensation (260)
COVID-19 (2557)
C-suite (109)
Data (1390)
Diabetes (173)
Diagnostics (6191)
Earnings (85020)
Employer resources (146)
Events (110510)
Executive appointments (396)
FDA (16799)
Funding (429)
Gene therapy (195)
GLP-1 (601)
Government (4347)
Healthcare (18713)
Infectious disease (2649)
Inflammatory bowel disease (115)
Interviews (309)
IPO (16372)
Job creations (3660)
Job search strategy (1430)
Layoffs (423)
Legal (7896)
Lung cancer (197)
Lymphoma (98)
Manufacturing (207)
Medical device (13222)
Medtech (13227)
Mergers & acquisitions (19269)
Metabolic disorders (454)
Neuroscience (1585)
NextGen Class of 2024 (6536)
Non-profit (4479)
Northern California (1697)
Obesity (258)
Opinion (187)
Patents (117)
People (56780)
Phase I (20177)
Phase II (28555)
Phase III (21268)
Pipeline (514)
Postmarket research (2561)
Preclinical (8576)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5936)
Regulatory (21730)
Research institute (2317)
Resumes & cover letters (350)
Southern California (1466)
Startups (3614)
United States (15192)
Vaccines (565)
Weight loss (182)
Date
Last 7 days (581)
Last 30 days (2256)
Last 365 days (35277)
2024 (35118)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54156)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (716)
Arizona (195)
Asia (37475)
Australia (6135)
California (3829)
Canada (1450)
China (305)
Colorado (172)
Connecticut (176)
Europe (80325)
Florida (533)
Georgia (135)
Illinois (387)
Indiana (225)
Maryland (627)
Massachusetts (2968)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1081)
North Carolina (743)
Northern California (1697)
Ohio (148)
Pennsylvania (925)
South America (1094)
Southern California (1466)
Texas (551)
Utah (108)
Washington State (400)
690,754 Results for "ensysce biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ensysce Biosciences Regains Compliance with Nasdaq
Ensysce Biosciences, Inc. today announced that it has received notice on May 24, 2024 from The Nasdaq Stock Market LLC that the Company has demonstrated compliance with the equity requirement in Listing Rule 5550(b).
May 28, 2024
·
3 min read
Press Releases
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
December 4, 2024
·
4 min read
Press Releases
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
December 10, 2024
·
4 min read
Press Releases
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
November 7, 2024
·
3 min read
Business
Ensysce Biosciences Reports First Quarter 2024 Financial Results
Ensysce Biosciences, Inc. today reported financial and operational results for the first quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Biotech Beach
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
Ensysce Biosciences, Inc. provides takeaways from Geoff Birkett, the Company’s Chief Commercial Officer, following his participation on the opening panel of the European Pharmaceutical Market Research Association (EPHMRA) Annual Conference in London on June 25.
June 27, 2024
·
5 min read
Press Releases
Ensysce Biosciences Reports Third Quarter 2024 Financial Results
November 12, 2024
·
11 min read
Biotech Beach
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Ensysce Biosciences, Inc. today announced the achievement of a critical milestone in its opioid use disorder (OUD) program with the selection of a lead drug candidate to move into Investigational New Drug (IND) enabling studies.
June 6, 2024
·
4 min read
Press Releases
Ensysce Biosciences Presenting at Upcoming Meetings
September 25, 2024
·
5 min read
Press Releases
Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
December 5, 2024
·
4 min read
1 of 69,076
Next
